Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/1996
05/07/1996US5514585 Yeast processing system
05/07/1996US5514582 Recombinant DNA encoding hybrid immunoglobulins
05/07/1996US5514581 Functional recombinantly prepared synthetic protein polymer
05/07/1996US5514578 Genetic engineering
05/07/1996US5514577 Oligonucleotide therapies for modulating the effects of herpes viruses
05/07/1996US5514576 Gene expression, engineering; dna sequence
05/07/1996US5514571 Cyclin D1 negative regulatory activity
05/07/1996US5514570 Squash mosaic virus genes and plants transformed therewith
05/07/1996US5514567 DNA and recombinant plasmid
05/07/1996US5514566 Methods of producing recombinant fibroblast growth factors
05/07/1996US5514565 Enzymatically-produced dimeric IL-2 and a nerve-derived transglutaminase enzyme for its preparation
05/07/1996US5514559 Immunologically active conjugates and method for their preparation
05/07/1996US5514555 Assays and therapeutic methods based on lymphocyte chemoattractants
05/07/1996US5514544 Dna sequences for genetic engineering
05/07/1996US5514541 T-lymphotropic retrovirus monoclonal antibodies
05/07/1996US5514539 Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
05/07/1996US5514409 Methods for coating invasive devices with inhibitors of thrombin
05/07/1996US5514375 Flavivirus recombinant poxvirus vaccine
05/07/1996CA1338320C Resorufin derivatives
05/07/1996CA1338310C Polycyclic peptide antibiotic and method for production thereof
05/07/1996CA1338309C Homologues of aprotinin produced from a recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof
05/02/1996WO1996012964A1 Receptor for a bacillus thuringiensis toxin
05/02/1996WO1996012825A1 CagB AND CagC GENES OF HELICOBACTER PYLORI AND RELATED METHODS AND COMPOSITIONS
05/02/1996WO1996012823A1 Cloned transcription factor regulating mhc expression
05/02/1996WO1996012816A1 Process for producing proteins
05/02/1996WO1996012811A2 Yeast telomerase components and methods using them
05/02/1996WO1996012810A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
05/02/1996WO1996012809A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
05/02/1996WO1996012808A1 Nucleic acid preparation for immunization and method for immunization using the same
05/02/1996WO1996012807A2 Hepatitis e virus antigens and uses therefor
05/02/1996WO1996012806A1 Calcineurin interacting protein compositions and methods
05/02/1996WO1996012805A1 Alk-7 (activin like kinase), a serine threonine kinase receptor
05/02/1996WO1996012804A2 Recombinant dna
05/02/1996WO1996012802A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/02/1996WO1996012801A1 Oral immunization with transgenic plants
05/02/1996WO1996012799A1 Neutralization of foof allergens by thioredoxin
05/02/1996WO1996012796A1 Conditional transformation of genetically engineered cells
05/02/1996WO1996012795A1 Cytoassay
05/02/1996WO1996012792A1 INTERLEUKIN-1β DEFICIENT TRANSGENIC ANIMALS
05/02/1996WO1996012791A1 Human abh
05/02/1996WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996WO1996012741A1 Binding agents to cd23
05/02/1996WO1996012740A1 SYNTHETIC IgE MEMBRANE ANCHOR PEPTIDE IMMUNOGENS FOR THE TREATMENT OF ALLERGY
05/02/1996WO1996012737A2 Compositions and treatment for multiple sclerosis
05/02/1996WO1996012736A2 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FILAMENT FORMATION AND NEUROTOXICITY
05/02/1996WO1996012735A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding
05/02/1996WO1996012734A1 Vaccine preparation recovered from bacteria grown in iron-rich media
05/02/1996WO1996012733A1 Major outer membrane protein cd of moraxella
05/02/1996WO1996012731A1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
05/02/1996WO1996012730A1 Separation of amino acids and peptides from protein hydrolysates
05/02/1996WO1996012544A1 A DIAGNOSTIC ASSAY FOR ALZHEIMER'S DISEASE: ASSESSMENT OF Aβ ABNORMALITIES
05/02/1996WO1996012506A1 Senescent cell-derived inhibitors of dna synthesis
05/02/1996WO1996012505A1 Conjugates of a polypeptide or oligopeptide with a low molecular weight lipophilic compound
05/02/1996WO1996012502A1 Method of culturing m. bovis in low available iron media and production of infectious bovine keratoconjunctivitis vaccine therefrom
05/02/1996WO1996009386A3 Allelic variation of the serotonin 5ht2c receptor
05/02/1996WO1996004011A3 Novel compound to mimic a naturally occurring peptide's effect
05/02/1996WO1996003435A3 FELINE η-INTERFERON
05/02/1996WO1996003151A3 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
05/02/1996WO1995027732A3 Circularly permuted ligands and circularly permuted chimeric molecules
05/02/1996DE4439748A1 Verfahren zur Veränderung des Blühverhaltens bei Pflanzen Processes for modifying the flowering behavior of plants
05/02/1996DE19509881A1 Ovoglycoprotein und dasselbe enthaltende Agens für chromatografische Aufspaltung Ovoglycoprotein and containing the same agent for chromatographic splitting
05/02/1996DE19500394A1 Peptide zur Diagnose, zum Nachweis und zur Prävention von Hepatitis C Virus (HCV)-Infektionen Peptides for diagnosis, for the detection and prevention of hepatitis C virus (HCV) infections
05/02/1996CA2652992A1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
05/02/1996CA2416318A1 Soluble, recombinant botulinum toxin proteins
05/02/1996CA2203825A1 Compounds and methods for inhibiting beta-protein filament formation and neurotoxicity
05/02/1996CA2203629A1 Compositions and treatment for multiple sclerosis
05/02/1996CA2203504A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/02/1996CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996CA2203363A1 Binding agents to cd23
05/02/1996CA2203165A1 Synthetic ige membrane anchor peptide immunogens for the treatment of allergy
05/02/1996CA2203105A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
05/02/1996CA2203018A1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
05/02/1996CA2202912A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding
05/02/1996CA2202130A1 Recombinant dna
05/02/1996CA2200427A1 Receptor for a bacillus thuringiensis toxin
05/01/1996EP0709710A1 Electro-optic modulator with transverse electrical configuration and method of manufacture thereof
05/01/1996EP0709460A1 Coccidiosis poultry vaccine
05/01/1996EP0709459A2 Modified biological material
05/01/1996EP0709397A1 p53as Protein and antibody therefor
05/01/1996EP0709396A1 Gamma T cell receptor and methods for detection
05/01/1996EP0709395A2 Preparation of stable insulin analog crystals
05/01/1996EP0708923A1 Recombinant 170 kd subunit lectin of entamoeba histolytica and methods of use
05/01/1996EP0708922A1 Identification of ligands by selective amplification of cells transfected with receptors
05/01/1996EP0708877A1 Method for repairing a combustion chamber assembly
05/01/1996EP0708841A1 Method of identifying human and animal cells capable of unlimited proliferation or tumour formation
05/01/1996EP0708838A1 Use of heparanase to identify and isolate anti-heparanase compound
05/01/1996EP0708834A1 FORMATION OF AND METHODS FOR THE PRODUCTION OF LARGE $i(BACILLUS THURINGIENSIS) CRYSTALS WITH INCREASED PESTICIDAL ACTIVITY
05/01/1996EP0708832A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto
05/01/1996EP0708831A1 Density enhanced protein tyrosine phosphatases
05/01/1996EP0708830A1 $i(BACILLUS THURINGIENSIS) ISOLATES AND TOXINS
05/01/1996EP0708784A1 COMPOUNDS HAVING THE ANTIGENICITY OF hCG
05/01/1996EP0708661A1 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
05/01/1996EP0708659A1 Hiv envelope polypeptides
05/01/1996EP0708658A1 Recombinant cytomegalovirus vaccine
05/01/1996EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
05/01/1996EP0708655A1 Methods of using insulin-like growth factor binding proteins
05/01/1996EP0708654A1 THF-$g(g)2 ANALOGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
05/01/1996EP0708592A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
05/01/1996EP0542845B1 Plasmodium falciparum antigen for eliciting protective antibodies for use in vaccines
05/01/1996EP0441917B1 Pokeweed antiviral protein - monoclonal antibody conjugates
1 ... 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 ... 2916